logo

For the Inventor, By the Inventor

Santa Ana, CA, United States of America

Dariusz Cieslak

This inventor holds 3 USPTO granted patents. Top assignee: Icn Pharmaceuticals, Inc.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dariusz Cieslak. Retrieved from https://idiyas.com/inventor/dariusz-cieslak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 69(Granted Patents)


Location History:

  • Santa Ana, CA (US) (1998 - 1999)
  • Laguna Niguel, CA (US) (2000)

Company Filing History:

goldMedal3 out of 46 
 
Icn Pharmaceuticals, Inc.
 patents

Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6017898 - Inhibition of tumor growth by antisense oligonucleotides for IL-8 and (2000-01-25),
2. 5990299 - Control of CD44 gene expression for therapeutic use (1999-11-23),
3. 5849903 - Antisense oligonucleotides for IL-8 and IL-8 receptor (1998-12-15),

Title: Top Inventor in Santa Ana

Introduction: John Mak is a prominent inventor based in Santa Ana, California. He has made significant contributions to his field and continues to innovate.

Latest Patents: John has recently been awarded several patents that showcase his inventive prowess.

Career Highlights: Throughout his career, John has achieved numerous milestones that highlight his expertise and dedication to innovation.

Collaborations: John has worked with various organizations and individuals, fostering partnerships that enhance his projects.

Conclusion: John Mak remains a key figure in the world of invention, with a bright future ahead.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…